BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11687969)

  • 1. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
    Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
    Magan N; Szremska AP; Isaacs RJ; Stowell KM
    Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM; Xie Z; Young MF; Nielsen KL
    J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
    Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D
    BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.
    Nicolás M; Noé V; Ciudad CJ
    Biochem J; 2003 Apr; 371(Pt 2):265-75. PubMed ID: 12513689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and expression of the promoter for the human type II transforming growth factor-beta receptor.
    Humphries DE; Bloom BB; Fine A; Goldstein RH
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1020-7. PubMed ID: 8093019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
    Bernadt CT; Rizzino A
    Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.
    Barth N; Langmann T; Schölmerich J; Schmitz G; Schäffler A
    Diabetologia; 2002 Oct; 45(10):1425-33. PubMed ID: 12378384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting.
    Chen X; Wright KL; Berkowitz EA; Azizkhan JC; Ting JP; Lee DC
    Oncogene; 1994 Nov; 9(11):3179-87. PubMed ID: 7936640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ
    Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
    Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of specific proteins (Sp1/Sp3) and nuclear factor Y in basal transcription of the distal promoter of the rat pyruvate carboxylase gene in beta-cells.
    Sunyakumthorn P; Boonsaen T; Boonsaeng V; Wallace JC; Jitrapakdee S
    Biochem Biophys Res Commun; 2005 Apr; 329(1):188-96. PubMed ID: 15721292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells.
    Nenoi M; Ichimura S; Mita K; Yukawa O; Cartwright IL
    Cancer Res; 2001 Aug; 61(15):5885-94. PubMed ID: 11479230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human EDF-1 minimal promoter: involvement of NFY and Sp1 in the regulation of basal transcription.
    Bolognese F; Pitarque-Martì M; Lo Cicero V; Mantovani R; Maier JA
    Gene; 2006 Jun; 374():87-95. PubMed ID: 16567061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.